Brendan is a partner at GV focusing on life sciences investments. Before GV, Brendan worked on applied statistics and machine learning research in genetics and biotechnology. Brendan led machine learning at Gritstone Oncology, where he designed machine learning models for personalized immuno-oncology therapeutics. Prior to that, he worked at the Broad Institute where he developed statistical methods for human genetics research. His research has been published in top journals including Nature, Science, Nature Biotechnology, and Nature Genetics.
Brendan holds a B.A. in mathematics from the University of California, Berkeley and a Ph.D. in statistical genetics from Vrije Universiteit Amsterdam.